[{"AccountsPayableCurrent_0_Q1_USD":98364000.0,"InterestIncomeExpenseNet_1_Q1_USD":6690000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1959818000.0,"ProceedsFromShortTermDebt_1_Q1_USD":11298000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q1_USD":256743000.0,"PrepaidInsurance_0_Q1_USD":4298000.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":12875000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-363590000.0,"ProceedsFromLongTermLinesOfCredit_1_Q1_USD":0.0,"PrepaidTaxes_0_Q1_USD":17392000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":5698000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1_Q1_USD":15775000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":11629000.0,"LongTermDebtCurrent_0_Q1_USD":11298000.0,"IncreaseDecreaseInIncomeTaxesReceivable_1_Q1_USD":5586000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":0.0,"DepreciationDepletionAndAmortization_1_Q1_USD":7750000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":37937000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-363385000.0,"TaxesPayableCurrent_0_Q1_USD":19535000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":1349000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":1453000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":-1308000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-362282000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":2022000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":38255000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":2162407000.0,"OtherAssetsNoncurrent_0_Q1_USD":94250000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-1204000.0,"MinorityInterest_0_Q1_USD":14842000.0,"DeferredIncomeTaxesAndTaxCredits_1_Q1_USD":-206000.0,"LongTermDebtNoncurrent_0_Q1_USD":81913000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-4349000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":27272000.0,"UnrecognizedTaxBenefits_0_Q1_USD":5003000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":6964000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":52059000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":2435000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":282000.0,"RestrictedCash_0_Q1_USD":2717000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":1240000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":1307179000.0,"OtherSundryLiabilitiesNoncurrent_0_Q1_USD":171000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":-1105000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q1_USD":2693000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":91509000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":32967000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":14597000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":38255000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":10917000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":2710000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":6080000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":563000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-6212000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":1339043000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":1417097000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":1410129000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":6968000.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_1_Q1_USD":0.0,"LongTermInvestments_0_Q1_USD":11964000.0,"OtherReceivablesNetCurrent_0_Q1_USD":6414000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":45305000.0,"InterestReceivableCurrent_0_Q1_USD":5941000.0,"UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_0_Q1_USD":117325000.0,"Goodwill_0_Q1_USD":109000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":750000.0,"ProfitLoss_1_Q1_USD":-364939000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":126312000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":21533000.0,"NetIncomeLoss_1_Q1_USD":-363735000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-341944000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-1114969000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2802168000.0,"LiabilitiesNoncurrent_0_Q1_USD":788359000.0,"LiabilitiesCurrent_0_Q1_USD":451797000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":4067212000.0,"Liabilities_0_Q1_USD":1240156000.0,"InventoryNet_0_Q1_USD":28775000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":36075000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-3236000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":240331000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-21450000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.36,"Depreciation_1_Q1_USD":7467000.0,"CostsAndExpenses_1_Q1_USD":425815000.0,"CommonStockValue_0_Q1_USD":101000.0,"CommonStockSharesOutstanding_0_Q1_shares":1007976816.0,"CommonStockSharesIssued_0_Q1_shares":1007976816.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1957101000.0,"AssetsNoncurrent_0_Q1_USD":472025000.0,"AssetsCurrent_0_Q1_USD":3595187000.0,"Assets_0_Q1_USD":4067212000.0,"AdditionalPaidInCapital_0_Q1_USD":5138239000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-6548000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":11944000.0,"AccountsReceivableNetCurrent_0_Q1_USD":65620000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":1554000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":750000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-2319578000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":1005347581.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":750000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":750000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":2000000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":14149000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":26412000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":2827056000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":3681000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":5563000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":8316000.0,"DueToRelatedPartiesNoncurrent_0_Q1_USD":157278000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":260728000.0,"InventoryWorkInProcess_0_Q1_USD":444000.0,"InventoryFinishedGoods_0_Q1_USD":28331000.0,"IncreaseDecreaseInInventories_1_Q1_USD":222000.0,"StockholdersEquity_0_Q1_USD":2812214000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":10368000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":43375000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":11629000.0,"ShareBasedCompensation_1_Q1_USD":38255000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":107081000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":304302000.0,"OperatingIncomeLoss_1_Q1_USD":-373756000.0,"InterestPaidNet_1_Q1_USD":1136000.0,"IncomeTaxesPaidNet_1_Q1_USD":531000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":2753000.0,"CommonStockSharesAuthorized_0_Q1_shares":9500000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":2022000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":179331000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":283000.0,"ValueAddedTaxReceivableNoncurrent_0_Q1_USD":32396000.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]